findmyKOL
Clinical trialNCT06493799RecruitingPhase 3Interventional

In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

SponsorGreen Cross WellbeingEnrollment226Chronic Liver Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Control group : LAENNEC subcutaneous injection (4 ml) Experimental group : LAENNEC intravenous injection (10 ml)
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Byoung Kuk Jang, Ph.D.

    1035, Dalgubeol-daero, Dalseo-gu, Daegu, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Chun Kyon Lee, Ph.D.

    100, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Eileen Laurel Yoon, Ph.D.

    222-1, Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Eun Ju Cho, Ph.D.

    101, Daehak-ro, Jongno-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Hyun Woong Lee, Ph.D.

    211, Eonju-ro, Gangnam-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Ja Kyung Kim, Ph.D.

    363, Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Jung Gil Park, Ph.D.

    70, Hyeonchung-ro, Nam-gu, Daegu, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Jung Hwan Yu, Ph.D.

    27, Inhang-ro, Jung-gu, Incheon, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Jung Hyun Kwon, Ph.D.

    56, Dongsu-ro, Bupyeong-gu, Incheon, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Sang Gyune Kim, Ph.D.

    170, Jomaru-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Seung Up Kim, Ph.D.

    50-1, Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Soo Young Park, Ph.D.

    807, Hoguk-ro, Buk-gu, Daegu, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Soung Won Jeong, Ph.D.

    59, Daesagwan-ro, Yongsan-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Won Hyeok Choe, Ph.D.

    120-1, Neungdong-ro, Gwangjin-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Won Sohn, Ph.D.

    29, Saemunan-ro, Jongno-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Young Kul Jung, Ph.D.

    123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Young Youn Cho, Ph.D.

    102, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea

    Study Director
    clinicaltrials.gov ↗
  • Yuri Cho, Ph.D.

    323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, Republic of Korea

    Study Director
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Gc Wellbeing

    Yongin-si, South Korea

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Human placenta hydrolysate
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2024
Primary completion
31 Mar 2026
Completion
30 Sept 2026
Last update posted
25 Feb 2026
Registered enrollment
226
Registry id
NCT06493799
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.